Melan-A specific CD8+ T lymphocytes after hyperthermic isolated limb perfusion: A pilot study in patients with in-transit metastases of malignant melanoma

International Journal of Hyperthermia

Volumn 29, Issue 3, 2013, Pages 234-238

  Olofsson, Roger ^a   Lindberg, Erika ^a   Karlsson Parra, Alex ^b   Lindnér, Per ^a   Mattsson, Jan ^a   Andersson, Bengt ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Immunology; Isolated limb perfusion; Regional perfusion

Indexed keywords

HLA A2 ANTIGEN; MELAN A; MELPHALAN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD ANALYSIS; CANCER SURGERY; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIA; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN-TRANSIT METASTASIS; ISOLATED ORGAN; LIMB PERFUSION; LYMPHOCYTE SUBPOPULATION; MALE; MELANOMA; MONOCYTE; NATURAL KILLER CELL; PHENOTYPE; PILOT STUDY; TREATMENT RESPONSE;

EID: 84876350858     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2013.782428     Document Type: Article

References (16)

1. Pawlik TM, Ross MI, Johnson MM, Schacherer CW, McClain DM, Mansfield PF, et al. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy. Ann Surg Oncol 2005; 12:587-96. (Pubitemid 41126088)
2. Creech Jr O, Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit. Ann Surg 1958;148:616-32.
3. Benckhuijsen C, Kroon BB, van Geel AN, Wieberdink J. Regional perfusion treatment with melphalan for melanoma in a limb: An evaluation of drug kinetics. Eur J Surg Oncol 1988;14: 157-63.
4. Stehlin Jr JS. Hyperthermic perfusion with chemotherapy for cancers of the extremities. Surg Gynecol Obstet 1969;129:305-8.
5. Moreno-Ramirez D, de la Cruz-Merino L, Ferrandiz L, Villegas-Portero R, Nieto-Garcia A. Isolated limb perfusion for malignant melanoma: Systematic review on effectiveness and safety. Oncologist 2010;15:416-27.
6. Boesch CE, Meyer T, Waschke L, Merkel S, Goehl J, Hohenberger W, et al. Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities. Int J Hyperthermia 2010;26:16-20.
7. Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, et al. Molecular characteristics of immunogenic cancer cell death. Cell Death Differ 2008;15:3-12. (Pubitemid 350286167)
8. Apetoh L, Mignot G, Panaretakis T, Kroemer G, Zitvogel L. Immunogenicity of anthracyclines: Moving towards more personalized medicine. Trends Mol Med 2008;14:141-51.
9. Schiavoni G, Sistigu A, Valentini M, Mattei F, Sestili P, Spadaro F, et al. Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis. Cancer Res 2011;71:768-78.
10. Eggermont AM, Schraffordt Koops H, Lienard D, Kroon BB, van Geel AN, Hoekstra HJ, et al. Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial. J Clin Oncol 1996;14:2653-65. (Pubitemid 26329649)
11. Schraffordt Koops H, Oldhoff J, Oosterhuis JW, Beekhuis H. Isolated regional perfusion in malignant melanoma of the extremities. World J Surg 1987;11:527-33. (Pubitemid 17137108)
12. World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: World Health Organization, 1979.
13. Galluzzi L, Senovilla L, Zitvogel L, Kroemer G. The secret ally: Immunostimulation by anticancer drugs. Nat Rev Drug Discov 2012;11:215-33.
14. Erdag G, Schaefer JT, Smolkin ME, Deacon DH, Shea SM, Dengel LT, et al. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res 2012;72: 1070-80.
15. Rivoltini L, Carrabba M, Huber V, Castelli C, Novellino L, Dalerba P, et al. Immunity to cancer: Attack and escape in T lymphocyte-tumor cell interaction. Immunol Rev 2002;188: 97-113. (Pubitemid 35398868)
16. Harlin H, Meng Y, Peterson AC, Zha Y, Tretiakova M, Slingluff C, et al. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res 2009;69:3077-85.